Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is pictured in the main lobby of GSK offices in London, Britain, February 20, 2025. REUTERS/Chris J. Ratcliffe ...

GSK plc GSK announced positive results from two phase III studies, B-Well 1 and B-Well 2, which evaluated its investigational chronic hepatitis B (CHB) therapy called bepirovirsen. Both studies met ...

A recall update has been published regarding a hepatitis B medication. The news comes as the Centers for Disease Control and Prevention (CDC) convenes to vote on updated guidelines for childhood ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

The prescribed dosage for Engerix-B (hepatitis B vaccine [recombinant]) may vary depending on your individual treatment plan. Other factors, including your medical history, may affect your dosage of ...

Engerix-B (hepatitis B vaccine [recombinant]) is a prescription vaccine that’s used to help prevent hepatitis B. Engerix-B comes as a liquid suspension for intramuscular injection. Engerix-B is used ...

St. Louis -- In a pair of articles published in Lancet Gastroenterology and Hepatology, scientists lay out the case for why we should expand treatment recommendations for people with hepatitis B.

Atomic force microscopy images show hepatitis B DNA in its natural state (left) and a zoomed-in look at how it wraps around human histones during an infection (right). The research team determined ...